Oak Street Health (NYSE:OSH – Get Rating) is one of 33 public companies in the “Health services” industry, but how does it contrast to its competitors? We will compare Oak Street Health to similar businesses based on the strength of its profitability, institutional ownership, valuation, dividends, analyst recommendations, risk and earnings.
Earnings & Valuation
This table compares Oak Street Health and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Oak Street Health||$1.43 billion||-$409.40 million||-8.47|
|Oak Street Health Competitors||$1.36 billion||-$98.47 million||29.16|
Oak Street Health has higher revenue, but lower earnings than its competitors. Oak Street Health is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
|Net Margins||Return on Equity||Return on Assets|
|Oak Street Health||-26.04%||-1,883.59%||-26.05%|
|Oak Street Health Competitors||-325.87%||-481.74%||-38.64%|
Insider and Institutional Ownership
91.3% of Oak Street Health shares are owned by institutional investors. Comparatively, 48.6% of shares of all “Health services” companies are owned by institutional investors. 11.4% of Oak Street Health shares are owned by insiders. Comparatively, 21.6% of shares of all “Health services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Volatility and Risk
Oak Street Health has a beta of 2.32, meaning that its stock price is 132% more volatile than the S&P 500. Comparatively, Oak Street Health’s competitors have a beta of 1.48, meaning that their average stock price is 48% more volatile than the S&P 500.
This is a summary of current ratings and recommmendations for Oak Street Health and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Oak Street Health||1||6||6||0||2.38|
|Oak Street Health Competitors||7||130||274||0||2.65|
Oak Street Health presently has a consensus target price of $30.87, suggesting a potential upside of 60.60%. As a group, “Health services” companies have a potential upside of 126.57%. Given Oak Street Health’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Oak Street Health has less favorable growth aspects than its competitors.
Oak Street Health competitors beat Oak Street Health on 7 of the 12 factors compared.
Oak Street Health Company Profile
Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.